+919405117673
Anti-D 300 mcg Injection Packaging, Storage & International Shipping from India to UK
Anti-D 300 mcg Injection is a human anti-D immunoglobulin product used under medical supervision for appropriate Rh(D)-related indications. For pharmaceutical buyers, hospitals, distributors, and healthcare procurement teams in the UK, proper packaging, temperature-controlled storage, and compliant international shipping from India to the UK are important for maintaining product quality throughout the supply chain.

Anti-D 300 mcg Injection Packaging

Anti-D 300 mcg Injection is packed according to pharmaceutical handling requirements to help protect the product during storage and transportation. The injection is generally supplied in its manufacturer-approved vial or prefilled presentation, together with appropriate secondary packaging.

For export orders from India to the UK, packaging can include:

Original manufacturer packaging and labeling
Secure secondary pharmaceutical packaging
Protective outer cartons to reduce the risk of damage during transit
Batch number and expiry information
Product documentation required for the shipment
Temperature-control packaging when required by the product's approved storage conditions

Bulk pharmaceutical orders can be prepared according to the agreed quantity, shipping method, and applicable import requirements.

Anti-D 300 mcg Injection Storage

Proper storage is essential for immunoglobulin products. Anti-D 300 mcg Injection should be stored strictly according to the manufacturer's approved product information and labeling. Where the product labeling specifies refrigerated storage, the required temperature range should be maintained throughout storage and transportation.

Important storage practices include:

Maintain the manufacturer's specified temperature range.
Protect the product from unsuitable temperature exposure.
Keep the injection in its original packaging until required.
Avoid freezing unless specifically permitted by the manufacturer.
Monitor temperature during temperature-sensitive transportation.
Follow the manufacturer's instructions regarding light protection and handling.

For UK-bound shipments, appropriate cold-chain procedures should be considered whenever required by the specific product presentation.

International Shipping of Anti-D 300 mcg Injection from India to UK

Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical supply and export requirements from India for international buyers. Anti-D 300 mcg Injection can be prepared for shipment to the UK subject to applicable pharmaceutical export, import, customs, and regulatory requirements.

International shipping may involve:

Order and product availability confirmation
Commercial quotation and quantity confirmation
Verification of applicable export and import documentation
Secure pharmaceutical packaging
Temperature-controlled shipping where required
Preparation of commercial and shipping documents
Customs clearance procedures
Shipment tracking and delivery coordination

The appropriate courier or freight method depends on the shipment size, destination, product storage requirements, and applicable regulations.

Anti-D 300 mcg Injection Supplier and Exporter from India

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical sourcing and export support for international customers seeking Anti-D 300 mcg Injection from India. Buyers can contact the company for product availability, packaging information, export documentation, shipping options, and quotation requirements.

UK pharmaceutical distributors, hospitals, healthcare procurement organizations, and authorized buyers should ensure that all applicable UK import and regulatory requirements are satisfied before placing an order.

Order Anti-D 300 mcg Injection from India to UK

For Anti-D 300 mcg Injection packaging, storage, and international shipping from India to the UK, contact Cordium Pharmaceuticals Pvt Ltd for availability and export-related information. Orders and shipments are handled according to applicable pharmaceutical, customs, transportation, and regulatory requirements.
Sep 11th, 2026 3:56 PM

Keywords